Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 46

1.

Gut microbiota was modulated by moxibustion stimulation in rats with irritable bowel syndrome.

Wang X, Qi Q, Wang Y, Wu H, Jin X, Yao H, Jin D, Liu Y, Wang C.

Chin Med. 2018 Dec 18;13:63. doi: 10.1186/s13020-018-0220-y. eCollection 2018.

2.

Bifidobacterium infantis M-63 improves mental health in victims with irritable bowel syndrome developed after a major flood disaster.

Ma ZF, Yusof N, Hamid N, Lawenko RM, Mohammad WMZW, Liong MT, Sugahara H, Odamaki T, Xiao J, Lee YY.

Benef Microbes. 2018 Dec 10:1-10. doi: 10.3920/BM2018.0008. [Epub ahead of print]

PMID:
30525951
3.

Intestinal Microbiome in Irritable Bowel Syndrome before and after Gut-Directed Hypnotherapy.

Peter J, Fournier C, Keip B, Rittershaus N, Stephanou-Rieser N, Durdevic M, Dejaco C, Michalski M, Moser G.

Int J Mol Sci. 2018 Nov 16;19(11). pii: E3619. doi: 10.3390/ijms19113619.

4.

Relationships of Microbiome Markers With Extraintestinal, Psychological Distress and Gastrointestinal Symptoms, and Quality of Life in Women With Irritable Bowel Syndrome.

Hollister EB, Cain KC, Shulman RJ, Jarrett ME, Burr RL, Ko C, Zia J, Han CJ, Heitkemper MM.

J Clin Gastroenterol. 2018 Aug 24. doi: 10.1097/MCG.0000000000001107. [Epub ahead of print]

PMID:
30148765
5.

Fecal Microbiota Alterations Associated With Diarrhea-Predominant Irritable Bowel Syndrome.

Zhuang X, Tian Z, Li L, Zeng Z, Chen M, Xiong L.

Front Microbiol. 2018 Jul 25;9:1600. doi: 10.3389/fmicb.2018.01600. eCollection 2018.

6.

Exposure to environmental microbiota explains persistent abdominal pain and irritable bowel syndrome after a major flood.

Yusof N, Hamid N, Ma ZF, Lawenko RM, Wan Mohammad WMZ, Collins DA, Liong MT, Odamaki T, Xiao J, Lee YY.

Gut Pathog. 2017 Dec 14;9:75. doi: 10.1186/s13099-017-0224-7. eCollection 2017.

7.

Postinfection Irritable Bowel Syndrome: The Links Between Gastroenteritis, Inflammation, the Microbiome, and Functional Disease.

Downs IA, Aroniadis OC, Kelly L, Brandt LJ.

J Clin Gastroenterol. 2017 Nov/Dec;51(10):869-877. doi: 10.1097/MCG.0000000000000924. Review.

PMID:
28885302
8.

Bifidobacteria and Their Health-Promoting Effects.

Hidalgo-Cantabrana C, Delgado S, Ruiz L, Ruas-Madiedo P, Sánchez B, Margolles A.

Microbiol Spectr. 2017 Jun;5(3). doi: 10.1128/microbiolspec.BAD-0010-2016. Review.

PMID:
28643627
9.

Differences in gut microbial composition correlate with regional brain volumes in irritable bowel syndrome.

Labus JS, Hollister EB, Jacobs J, Kirbach K, Oezguen N, Gupta A, Acosta J, Luna RA, Aagaard K, Versalovic J, Savidge T, Hsiao E, Tillisch K, Mayer EA.

Microbiome. 2017 May 1;5(1):49. doi: 10.1186/s40168-017-0260-z.

10.

Identification of an Intestinal Microbiota Signature Associated With Severity of Irritable Bowel Syndrome.

Tap J, Derrien M, Törnblom H, Brazeilles R, Cools-Portier S, Doré J, Störsrud S, Le Nevé B, Öhman L, Simrén M.

Gastroenterology. 2017 Jan;152(1):111-123.e8. doi: 10.1053/j.gastro.2016.09.049. Epub 2016 Oct 7.

11.

Limited prolonged effects of rifaximin treatment on irritable bowel syndrome-related differences in the fecal microbiome and metabolome.

Zeber-Lubecka N, Kulecka M, Ambrozkiewicz F, Paziewska A, Goryca K, Karczmarski J, Rubel T, Wojtowicz W, Mlynarz P, Marczak L, Tomecki R, Mikula M, Ostrowski J.

Gut Microbes. 2016 Sep 2;7(5):397-413. doi: 10.1080/19490976.2016.1215805. Epub 2016 Jul 26.

12.

Comparison of faecal microbiota in Blastocystis-positive and Blastocystis-negative irritable bowel syndrome patients.

Nagel R, Traub RJ, Allcock RJ, Kwan MM, Bielefeldt-Ohmann H.

Microbiome. 2016 Aug 31;4(1):47. doi: 10.1186/s40168-016-0191-0.

13.

[The correlation study between the changes of intestinal mucosa predominant bacteria and Toll-like receptor 2, Toll-like receptor 4 gene expressions in diarrhea-predominant irritable bowel syndrome patients].

Guo WT, Liu P, Dong LN, Wang JP.

Zhonghua Nei Ke Za Zhi. 2016 Jul 1;55(7):541-3. doi: 10.3760/cma.j.issn.0578-1426.2016.07.011. Chinese.

PMID:
27373290
14.

The microbiome of the oral mucosa in irritable bowel syndrome.

Fourie NH, Wang D, Abey SK, Sherwin LB, Joseph PV, Rahim-Williams B, Ferguson EG, Henderson WA.

Gut Microbes. 2016 Jul 3;7(4):286-301. Epub 2016 Mar 10.

15.

Modulation of the gut microbiota composition by rifaximin in non-constipated irritable bowel syndrome patients: a molecular approach.

Soldi S, Vasileiadis S, Uggeri F, Campanale M, Morelli L, Fogli MV, Calanni F, Grimaldi M, Gasbarrini A.

Clin Exp Gastroenterol. 2015 Dec 4;8:309-25. doi: 10.2147/CEG.S89999. eCollection 2015.

16.

Differences of microbiota in small bowel and faeces between irritable bowel syndrome patients and healthy subjects.

Chung CS, Chang PF, Liao CH, Lee TH, Chen Y, Lee YC, Wu MS, Wang HP, Ni YH.

Scand J Gastroenterol. 2016;51(4):410-9. doi: 10.3109/00365521.2015.1116107. Epub 2015 Nov 23.

PMID:
26595305
17.

Relationship Between Microbiota of the Colonic Mucosa vs Feces and Symptoms, Colonic Transit, and Methane Production in Female Patients With Chronic Constipation.

Parthasarathy G, Chen J, Chen X, Chia N, O'Connor HM, Wolf PG, Gaskins HR, Bharucha AE.

Gastroenterology. 2016 Feb;150(2):367-79.e1. doi: 10.1053/j.gastro.2015.10.005. Epub 2015 Oct 13.

18.

The relationship between faecal-associated and mucosal-associated microbiota in irritable bowel syndrome patients and healthy subjects.

Rangel I, Sundin J, Fuentes S, Repsilber D, de Vos WM, Brummer RJ.

Aliment Pharmacol Ther. 2015 Nov;42(10):1211-21. doi: 10.1111/apt.13399. Epub 2015 Sep 17.

19.

Human microbiome: From the bathroom to the bedside.

Malnick S, Melzer E.

World J Gastrointest Pathophysiol. 2015 Aug 15;6(3):79-85. doi: 10.4291/wjgp.v6.i3.79. Review.

20.

Reduction of butyrate- and methane-producing microorganisms in patients with Irritable Bowel Syndrome.

Pozuelo M, Panda S, Santiago A, Mendez S, Accarino A, Santos J, Guarner F, Azpiroz F, Manichanh C.

Sci Rep. 2015 Aug 4;5:12693. doi: 10.1038/srep12693.

Supplemental Content

Loading ...
Support Center